What is the procedure for investigation of an OOS (Out of
specification) results?
Answer Posted / b.suresh naidu
OOS may be due to assignable cause (or) Non-assignable
cause.
Assignable cause: It means error is identified.
Non-assignable cause: It means error is not identified.
When any OOS result is observed, first to know any
assignable cause Laboratory preliminary investigation
(Phase-I) is recommended. Phase I investigation should
contain whether correct methododology followed as per STP,
used calibrated instruments,Analyst trained & re-injection,
re-filtration, re-dilution, re-sonication from the
original stock solutions, _ _ _etc).
If any Laboratory error is identified then repeat analysis
as defined in the SOP [Min it should be NLT 6 replicates by
two different analysts (preferably Original analyst &
experienced analyst)]
If no Laboratory error is identified, then full scale
investigation (Phase-II) is recommended. Phase-II
investigation should contain atleast Manufacturing,
Packaging, sampling/re-sampling, _ _ _etc.This sholud be
clearly defined in the SOP.
If any assignable cause is identified then repeat analysis
as defined in the SOP [Min it should be NLT 6 replicates by
two different analysts (preferably Original analyst &
experienced analyst)].If no assignable cause is identified
in phase-II investigation, then further investigation/
batch disposition shall be done as recommended by QA.
Further more details refer CDER guidelines from USFDA.
Is This Answer Correct ? | 35 Yes | 1 No |
Post New Answer View All Answers
In Assy by potentio metry titration method how select MET U ,DET U, SET U,
What is the Formula for coreletion coefficient in plhplc calibration
what is impurity profile. how to interpret this impurity profile to a drug product or drug substance.
what type of question will ask in the interview of lab chemist.
what is the origin to prepare standard operating procedure
if tech transfer fails whay require to do?
EXPLAIN THE CALCULATION PART OF AN KF TITRATOR CALIBRATION WITH SUITABLE EXAMPLE
which are the sizes of capsules?
identification is for unknown? qualification for known? reporting for LOQ?
Difference between hlaf and rlaf
if your impurity coeluting with each other in that situation how require to set specification? is it acceptable?
what is the purge flow & how to calculate
In BP2013, Loperamid HCl monograph. Assay by titration with 0.1N sodium hydroxide using hydrocloric acid 0.01N and reading the volume added between the 2 points of inflexion. I have a question that if the diluent solvent is ethanol is certainly consumed a amount of volume of titrant, so this volume must be eliminated on the result calculation or not apart from first point which is subtracted above.
how to calculate elemental impurities?
From where require to take the RLD sample?